136
Views
8
CrossRef citations to date
0
Altmetric
Hematological Malignancy: Malignant lymphoma

Detection of Epstein–Barr virus in children and adolescents with Burkitt's lymphoma by in situ hybridization using tissue microarrays

, , , , , , & show all
Pages 114-118 | Published online: 18 Jul 2013

References

  • Young JL Jr, Miller RW. Incidence of malignant tumors in US children. J Pediatr 1975; 86: 254–258.
  • Naresh KN, Agarwal B, Nathwani BN et al. Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists. Leuk Lymphoma 2004; 45: 1569–1577.
  • Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005; 5: 251–562.
  • Reiter A, Schrappe M, Tiemann M et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 1999; 94: 3294–3306.
  • Burkitt D. A sarcoma involving the jaws in African children. BritSurg 1958; 46: 218–223.
  • Burkitt DP. The discovery of Burkitt's lymphoma. Cancer 1983;51: 1777–1786.
  • Rasti N, Falk KI, Donati D et al. Circulating epstein-barr virus inchildren living in malaria-endemic areas. Scand J Immunol 2005; 61: 461–465.
  • Gutierrez MI, Bhatia K, Barriga F et al. Molecular epidemiologyof Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 1992; 79: 3261–3266.
  • Lobo-Sanahuja F, Garcia I, Barrantes JC, Barrantes M, Jimenez R, Arguello A. Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment. Med Pediatr Oncol 1994; 22: 194–199.
  • de Andrea ML. Linfoma não-Hodgkin na infancia. Rev Paul Pediatr 1990; 8: 43–46.
  • Sandlund Tr, Fonseca T, Leimig T et al. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil. Leukemia 1997; 11:743–746.
  • Pizza M. Linfoma de Burkitt: avaliação clinica, laboratorial, tratamento e prognöstico. Arq Med Hosp Fac Santa Casa Sao Paulo 2003; 48: 58–64.
  • Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702–703.
  • Hurley EA, Thorley-Lawson DA. B cell activation and the establishment of Epstein-Barr virus latency. J Exp Med 1988; 168: 2059–2075.
  • Gulley ML, Raphael M, Lutz CT, Ross DW, Raab-Traub N. Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer 1992; 80: 185–191.
  • Wilson JB, Bell JL, Levine AJ. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 1996; 15: 3117–3126.
  • Hopwood P, Crawford DH. The role of EBV in post-transplant malignancies: a review. J Clin Pathol 2000; 53: 248–254.
  • Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844–847.
  • Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lym-phomas in adults. Semin Oncol 1980; 7: 332–339.
  • Murphy SB, Bowman WP, Abromowitch M et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg +) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Cliii Oncol 1986; 4: 1732–1739.
  • Patte C, Philip T, Rodary C et al. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 1986; 4: 1219–1226.
  • Patte C, Philip T, Rodary C et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Cliii Oncol 1991; 9: 123–132.
  • de Andrea ML, de Camargo B, Correa Alves A, Machado JC, Franco EL. Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach. Cancer 1988; 62: 240–250.
  • Klumb CE, Schramm MT, Resende LMM et al. Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. J Pediatr Hematol Oncol 2004; 26: 462–468.
  • Bacchi MM, Bacchi CE, Alvarenga M, Miranda R, Chen YY, Weiss LM. Burkitt's lymphoma in Brazil: strong association with Epstein-Barr virus. Mod Pathol 1996; 9: 63–67.
  • Klumb CE, Hassan R, de Oliveira DE et al. Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil. Int J Cancer 2004; 108: 66–70.
  • Figueira CMG. Detecção do genoma viral em tecido neoplásico e analise da translocação cromossomial em pacientes com linfoma de Burkitt associado ao vírus de Epstein-Barr em diferentes regiiies do Brasil: uma correlação clinica e prognostica [Tese de Doutorado]. Sào Paulo: Universidade Federal de Sào Paulo. Escola Paulista de Medicina; 2006.
  • Araujo I, Foss HD, Bittencourt At al. Expression of Epstein-Barrvirus-gene products in Burkitt's lymphoma in Northeast Brazil. Blood 1996; 87: 5279–5286.
  • Quintanilla-Martinez L, Lome-Maldonado C, Ott G et al. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases. Blood 1997; 89: 644–561.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.